Cancer
VOICES of Black Women: A community study in cancer prevention and care
4/23/2026
A new study focused on stories will change health outcomes for Black women.
Leading the way: Providence researchers at AACR Annual Meeting
4/22/2026
The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.
Treatment options, time, and hope for one family's "chief memory maker"
4/17/2026
After Virginia Kuo was diagnosed with lung cancer, Providence Swedish experts were committed to helping this mom of three have the life she envisioned with her husband and family. Learn more
A quiet lifeline: Meet the volunteer at Jill Lematta Learning Center
4/23/2026
Cancer resources and compassion are plentiful in a quiet space at Providence Cancer Institute Franz Clinic.
Colon Cancer Is Rising in Younger Adults—Why Early Detection Matters More Than Ever
3/31/2026
Colon cancer is no longer a disease that patients can assume only affects older adults. Colon Cancer Is Rising in Younger Adults—& Early Detection Matters More Than Ever
Gene therapy shows promising results against multiple myeloma
4/1/2026
This study is now enrolling patients at Providence Cancer Institute – the only site outside of Australia.
Q&A: Colon cancer in younger adults, when to screen, symptoms and prevention
3/30/2026
Dr. Kelly Perlewitz answers timely questions about the rise of colon cancer cases in younger adults.
Celebrating oncology social workers: Compassion, expertise and impact
3/20/2026
We celebrate the work of oncology social workers, whose work is essential, transformative and deeply human.
6 things everyone should know about oncology palliative care
3/31/2026
Palliative care can help manage pain, fatigue, anxiety and so much more – at any stage of cancer treatment.
Prostate cancer screening: What men need to know
Prostate cancer screening saves lives. Learn when to start PSA testing, what results mean, and how men in North Puget Sound can make informed screening decisions.
Providence receives Pfizer-funded Conquer Cancer grant to use revolutionary AI tool to predict cancer mutations
3/24/2026
Pfizer Global Medical Grants has awarded $250,000 for Providence to use Prov-GigaPath to predict cancer mutations among Oregon patients
Clinical trial seeks better first-line therapy for follicular lymphoma
2/23/2026
The study may redefine care for many people at the earliest stage of their treatment.
Where curiosity meets impact: Women in science at Providence Cancer Institute
2/10/2026
Get to know the women of the Immune Monitoring Laboratory and how their curiosity, tenacity and passion are driving progress in cancer research at Providence Cancer Institute.
Providence Alaska Medical Center recognized for high-quality cancer care
2/6/2026
Providence Alaska Medical Center has earned a three‑year accreditation from the American College of Surgeons Commission on Cancer Accreditation Program.
Why patients in rural areas need access to quality clinical trials
1/21/2026
Dr. Natasha Edwin advocates for making more quality clinical trials available for patients in rural communities.
A new strategy for treating locally advanced cervical cancer
1/21/2026
A new study aims to move cervical cancer care forward and improve the chance of long-term remission for more patients.
Trust gap a key driver of underrepresentation of racially and ethnically diverse communities in medical research, Providence study reveals
1/12/2026
Researchers develop framework for health systems to build bridges and engage Black, Latino and American Indian communities in medical research
Personalizing lymphoma treatment: New study seeks better outcomes
12/29/2025
A targeted therapy being evaluated in a clinical trial may improve survival for high-risk patients with diffuse large B-cell lymphoma.
From patient to volunteer: Marge’s gift of gratitude
12/17/2025
Marge received treatment for pancreatic cancer at Providence Cancer Institute and then volunteered in the infusion center to help the care team that supported her.
Reflecting on 2025, building toward 2026
12/30/2025
Catch the 2025 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.
New Providence study finds alcohol use, comorbidities among risk factors for early onset colorectal cancer
12/18/2025
A new Providence study shows that alcohol use, diabetes and other comorbidities could be risk factors for early onset colorectal cancer among people younger than 45.
Novel AI framework anticipated to unlock tumor secrets, lead to new treatments
12/9/2025
Providence, Microsoft Research, University of Washington unveil GigaTIME, an AI-powered pathology breakthrough set to transform cancer immunotherapy research
Introducing Prevention4ME: A new era in breast cancer risk assessment and early detection
11/20/2025
Providence Breast Care and Breast Surgery Clinics launch Prevention4ME, a groundbreaking program to empower women with personalized breast cancer risk assessments and proactive screening options.
A precision oncology revolution is underway at Providence
11/7/2025
Celebrating World Cancer Day with a look at the work of Carlo Bifulco, M.D. as he helps lead advancements in AI-driven, accessible precision oncology at Providence Cancer Institute.
2025 SITC Meeting: Three Providence researchers honored at 40th anniversary
2/4/2026
Providence Cancer Institute researchers share important cancer research at SITC annual meeting and receive recognition for their contributions to science.
Transforming outcomes in AML and breast cancer: Three open trials at Providence
2/4/2026
New studies at Providence Cancer Institute offer hope to patients with limited treatment options.
Oregon cancer leaders unite to discuss research and policy
10/17/2025
Providence Cancer Institute leader joined experts in cancer research, policy and advocacy to discuss current challenges and the future of research.
Lobular Breast Cancer: Exploring Current Knowledge and Advancing Understanding of This Understudied Disease.
10/24/2025
Providence medical breast oncologist to give a special presentation on Lobular Breast Cancer and the latest data on the development of a lobular prevention vaccine.
Next generation therapy for men with mCRPC may extend survival
9/29/2025
A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.
Providence and its Foundation bring advanced mobile breast cancer detection to Southcentral Alaska
10/2/2025
Providence Alaska is excited to introduce its newest state-of-the-art mobile mammography coach, equipped to bring advanced breast cancer detection technology directly to communities.